Recursion Pharmaceuticals, Inc. (RXRX)
4.67
+0.03
(+0.65%)
USD |
NASDAQ |
Jan 16, 16:00
4.465
-0.20
(-4.39%)
Pre-Market: 09:29
Recursion Pharmaceuticals Total Liabilities (Quarterly): 352.58M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 1.652B |
| XOMA Royalty Corp. | 155.19M |
| Mirum Pharmaceuticals, Inc. | 493.07M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Amicus Therapeutics, Inc. | 638.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.400B |
| Shareholders Equity (Quarterly) | 1.047B |
| Debt to Equity Ratio | 0.0787 |
| Current Ratio | 4.604 |
| Net Debt Paydown Yield | 0.06% |